JDD August 2026 Highlights and Editor Picks Missed any of our July highlights? August is our Psoriasis and Other Inflammatory Conditions issue and is packed with intriguing articles, and you’ll…
Read More
Unlocking Expert Consensus on Sensitive Skin Syndrome: Key Takeaways for Practice A This is a must-read article from the JDD for clinicians seeking to refine their clinical approach to complex…
Read More
Advancing Hair Loss Solutions As August marks Hair Loss Awareness Month, the Journal of Drugs in Dermatology (JDD) continues to champion evidence-based approaches for practicing dermatologists navigating this challenging field.…
Read More
Guest: Dr. Adelina Hung For decades, corticosteroids have been the gastrointestinal equivalent of duct tape: they fix almost everything, at least long enough to convince us the job is done.…
Read More
GLP-1 Receptor Agonists and Psoriasis: The Next Frontier in Metabolic Dermatology? A groundbreaking study published in the Journal of Drugs in Dermatology highlights a compelling link between metabolic therapy and…
Read More
Check Out JDD’s Latest Author Spotlight Our current Author Spotlight features Nada Elbuluk, MD, MSc, FAAD, one of the co-authors of Public Interest in Hyperpigmentation: Insights From a Google Trends…
Read More
Your ultimate, comprehensive hub for everything related to pigmentary disorders. Whether you are looking to deepen your clinical knowledge, catch up on the latest dermatological breakthroughs, or optimize your patient…
Read More
Targeted Topical Approaches in Acanthosis Nigricans: Evaluating Sirolimus Gel 0.2% This is a must-read article from the JDD for clinicians treating complex pigmentary and metabolic dermatoses. Acanthosis nigricans remains a…
Read More
Exploring the Potential of Moringa Formulations in Hair Health and Alopecia Management Have you read this compelling new systematic review from the Journal of Drugs in Dermatology. As hair loss,…
Read More
Skin of Color: Bridging the Knowledge Gap As the patient population becomes more diverse in the United States, it is becoming increasingly important for dermatologists to be comfortable counseling patients…
Read More
MedPage Today/Dermatology World Weekly highlighted a Journal of Drugs in Dermatology study comparing a topical JAK inhibitor with a common topical steroid in atopic dermatitis (AD). The study, “Ruxolitinib Cream…
Read More
Remember when PASI 75 was the gold medal? Today, it barely makes the podium. In this episode of the JDD Podcast, host Dr. Adam Friedman welcomes Dr. James Song for…
Read More
